Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
7 November 2014
Header
Header image
Highlight of the week

News

EFPIA and Innovative Medicines Initiative Announce Programme to Help Respond to Ebola Crisis
06 November 2014

(6 November 2014 - Brussels): EFPIA, its specialised group Vaccines Europe, and the Innovative Medicines Initiative are pleased to announce the launch of a €280 [...] Read more

From our blog

From our blog

IMI2: We Are Proud to be Part of the Global Effort Against Ebola
06 November 2014 by Magda Chlebus

The current outbreak of Ebola and the fight against haemorrhagic fevers in general is an example of a challenge that requires multiple initiatives and joining forces of the entire biomedical community.

Read more

Events calendar

Events Calendar

“Development Pathways for Advanced Therapy Medicinal Products”
On 15/12/2014 (London, UK )

3rd Edition – A workshop organised by EBE in collaboration with European Medicines Agency and the Italian Embassy’s Scientific Office in London Chairs: Eduardo Bravo, EBE Vice President [...] Read more

Events Calendar

FT Global Pharmaceutical and Biotechnology Conference - Predictions 2020: The Future of the Industry
From 17/11/2014 to 18/11/2014 (London, UK )

The future is arriving fast for the life science industry. Convergence is happening along the entirety of the industry value chain, blurring the boundaries between pharma, biotech, [...] Read more

Documents

From our blog

Trade, Growth and Intellectual Property – Strategy for the protection and enforcement of intellectual property rights in third countries
04 November 2014 (Position Papers)

The EU depends on industries that rely on effective IP protection. As the representative of one of the EU’s most IP-intense industries, EFPIA welcomes this [...] Read more

What we are reading

What we are reading

IMI 2 - Call 2 2014 - Ebola and other filoviral haemorrhagic fevers
06 November 2014

The indicative IMI2 JU financial contribution for the 5 topics mentioned in this Call is up to €140 million.EFPIA companies are expected to provide an in-kind contribution of around €140 million.

Read more

What we are reading

FT Health and the Workplace
06 November 2014

Public and private sectors are investing in health programmes to aid productivity, says Andrew Ward. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail